About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Not Yet RecruitingNA

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

Radiofrequency Ablation Via Catheter and Transpapillary Access in Patients With Cholangiocarcinoma

NCT06175845•Universitätsklinikum Hamburg-Eppendorf

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

CholangiocarcinomaKlatskin TumorBile Duct Cancer+1 more

Interventions

Intraductal biliary radiofrequency ablation

Locations

1

Germany

Locations (1)

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

Key Dates

Start Date

February 1, 2024

Primary Completion Date

January 1, 2026

Completion Date

July 1, 2026

Last Updated

December 19, 2023

Related Studies

RECRUITINGPhase 2

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

NCT07282912

Foregut AdenocarcinomaEsophageal Adenocarcinoma+7 more

RECRUITINGPhase 2

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

NCT07146646

Biliary Tract CancerBiliary Tract Neoplasms+3 more

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

NCT04753996

Primary Sclerosing CholangitisPSC+1 more

RECRUITINGPhase 2

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

NCT05430698

Perihilar Cholangiocarcinoma

RECRUITINGPhase 2

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

NCT06313203

Intrahepatic CholangiocarcinomaChemotherapy Effect

RECRUITINGPhase 1/2

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

NCT04421820

Colorectal CancerPancreatic Cancer+2 more

View all related studies

Sponsors

Lead Sponsor

Universitätsklinikum Hamburg-Eppendorf

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions